Analysts at StockNews.com initiated coverage on shares of AMCON Distributing (NYSEAMERICAN:DIT – Get Free Report) in a research report issued on Tuesday. The firm set a “hold” rating on the stock.
AMCON Distributing Price Performance
NYSEAMERICAN DIT opened at $132.85 on Tuesday. The firm has a market cap of $83.70 million, a price-to-earnings ratio of 13.25 and a beta of 0.54. The company has a current ratio of 3.05, a quick ratio of 1.15 and a debt-to-equity ratio of 1.59. AMCON Distributing has a fifty-two week low of $118.25 and a fifty-two week high of $209.50.
Hedge Funds Weigh In On AMCON Distributing
A hedge fund recently raised its stake in AMCON Distributing stock. Empowered Funds LLC raised its stake in AMCON Distributing (NYSEAMERICAN:DIT – Free Report) by 7.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,442 shares of the company’s stock after purchasing an additional 175 shares during the period. Empowered Funds LLC owned about 0.39% of AMCON Distributing worth $449,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 11.14% of the stock is owned by institutional investors and hedge funds.
AMCON Distributing Company Profile
AMCON Distributing Company, together with its subsidiaries, engages in the wholesale distribution of consumer products in the Central, Rocky Mountain, and Mid-South regions of the United States. It operates through Wholesale Distribution and Retail Health Food segments. The Wholesale Distribution segment distributes consumer products, including cigarettes and tobacco products, candy and other confectionery, beverages, groceries, paper products, health and beauty care products, frozen and refrigerated products, and institutional foodservice products.
Further Reading
- Five stocks we like better than AMCON Distributing
- Stock Splits, Do They Really Impact Investors?
- Intel: Is Now the Time to Be Brave?Â
- What to Know About Investing in Penny Stocks
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 Healthcare Dividend Stocks to Buy
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for AMCON Distributing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMCON Distributing and related companies with MarketBeat.com's FREE daily email newsletter.